President Donald Trump struck a second deal last month with the world’s largest drugmakers, promising lower costs for American patients. The industry claims cooperation , offering help for consumers and expanded domestic production. Yet those same companies have raised prices on nearly 700 prescription drugs since January.

Big Pharma hopes the most unconventional president will fall back on the most conventional policy: granting the largest firms regulatory advantages, taxpayer-funded promotion, and freedom to keep ratcheting prices upward.

Trump should expose the game Big Pharma has played for years and force the industry to compete in a real marketplace.

Trump’s instincts are right. Americans pay inflated prices, and he has confronted the industry’s excesses. But Big Pharma sp

See Full Page